News
Pharmaceutical Technology on MSN21h
Epsilogen acquires TigaTx to expand pan-isotope cancer antibody pipelineUK biotech Epsilogen has acquired US-based antibody developer TigaTx in a deal that collates work from the two companies’ ...
Epsilogen completes acquisition of TigaTx to create world’s leading pan-isotype cancer antibody company: London Tuesday, April 8, 2025, 10:00 Hrs [IST] Epsilogen, the global lea ...
U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback